We use cookies. By closing this message or continuing to browse the site, you are agreeing to our use of cookies on this device.

RenovaLase®

Vaginal Atrophy Laser Treatment

RenovaLase® is a unique and innovative, non-invasive 2940 nm Er:YAG laser therapy for the symptoms of vaginal atrophy. It is based on non-ablative photothermal treatment of the vaginal canal. Clinical studies show that it is an efficient, easy-to-use, quick and safe procedure that eliminates the need for long-term estrogen administration.

How does RenovaLase® work?

The RenovaLase treatment is based on laser-induced, mild and controlled heating of the vaginal tissue, which stimulates angiogenesis, fibroblast activity and new collagen formation without thermal or ablative damage. The final result is increased epithelial thickness as well as vascularization of the lamina propria, along with a reduction of symptoms such as dryness, itching, irritation and dyspareunia.

Promising clinical Results

Scientific results presented by Dr. Marco Gambacciani and Dr. Adrian Gaspar (see Library tab) clearly show a noticeable improvement in the symptoms of vaginal atrophy. Results show favorable changes in the tropism of the vaginal mucosa, with increases in collagen and vascularization as well as in the glycogen level and the epithelial thickness. The positive effects were long lasting as results were sustained at follow-up 6 months after the treatment.

With no need for long-term estrogen treatment, RenovaLase® is also appropriate for patients with estrogen-dependent cancer (such as endometrial cancer, breast cancer, etc.) or with a family background of such cancers, as shown in clinical studies by Dr. Juan F. Bojanini and Dr. Marco Gambacciani (see Scientific & Clinical Research).

Read more

Clinical Results

Genitourinary Syndrome of Menopause

Scientific & Clinical Research

Testimonials